Description
SAMPLE TYPE: BLOOD
Requires venous extraction (no prior fasting necessary)
RESULTS: 20 DAYS
Results delivered from sample reception
The GNT. Polycythemia Vera JAK2 evaluates the presence of the V617F variant in the JAK2 gene, associated with myeloproliferative neoplasms and, characteristically, with polycythemia vera (PV).
This test requires a medical prescription. The requesting healthcare professional must ensure that the patient receives adequate genetic information and counseling, as well as the correct clinical interpretation of the results.
- Patients with erythrocytosis/elevated hematocrit and suspected myeloproliferative neoplasm.
- Diagnostic differentiation between polycythemia vera and secondary erythrocytosis (hypoxia, tobacco, drugs/EPO, sleep apnea, etc.).
JAK2: V617F variant
For more information, contact the Teletest administration department at 932 12 33 45 or through the following form

BUDGETS
ACCESS TO YOUR TESTS
MY RESULTS
PROFESSIONAL ACCESS
